Database

BE Health Ventures

Introduction
BE Health Ventures is an accelerator and venture investment firm focused on Healthtech and Medtech. Headquartered in Taipei, Taiwan, the accelerator leverages its ecosystem advantages to serve as a gateway for local and international startups entering Asia. Given the complexity and inherent risks of the healthcare sector, it has traditionally been a challenging environment for startups. However, BE Health Ventures connects startups with hospitals, research institutions, investors, medical experts, and other industry partners. Understanding the unique characteristics of the healthcare industry, it provides startups with the resources necessary for success, including capital, talent, and time.




more ↓
Country
Taiwan
Unified Business No.
50875317
Investors Type
Venture Capital、Startup Accelerator
Funding Rounds
Pre-Series A、Series A、Series B、Series C
NDF Collaborated Investor
No

More Similar Investors

Top Taiwan Venture Capital Group

Top Taiwan Venture Capital Group independently manages funds exceeding NT$12 billion and assists the National Development Fund, the Industrial Development Bureau, and the Small and Medium Enterprise Administration in investing and supporting domestic companies. CID focuses on globally competitive businesses, internationally scalable services, China’s domestic-demand-driven sectors, as well as biopharma, new drugs, equipment, and distribution services within the biotech and healthcare industries, along with other innovative growth-oriented businesses.

Cherubic Ventures

Cherubic Ventures is the only institutional angel investment firm active across both China and the U.S., with teams based in San Francisco, Beijing, and Taipei. Founded in 2014, it currently manages assets of over US$300 million. Representative investments include Flexport, hims, Calm, Virgin Hyperloop One, Wish, Ring, Liulishuo (LAIX), Pinkoi, and iKala.

WI Harper Group

WI Harper Group, established in 1993, is a U.S.-based venture capital firm specializing in early- and growth-stage investments. It currently manages eight venture funds with nearly US$1 billion in assets under management. Its investment focus lies in high-tech, digital new media (TMT), and healthcare, with a track record of over 350 portfolio companies and more than 80 successful IPO and M&A exits.
:::
回頁面最頂端